3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
Burkitt Lymphoma
30
Leukemia, Biphenotypic, Acute
7
Neoplasm, Residual
6
Leukemia
6
Recurrence
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Lymphoma, Non-Hodgkin
3
Blast Crisis
3
Myelodysplastic Syndromes
2
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myeloid
2
Down Syndrome
2
Sarcoma, Myeloid
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Bites and Stings
1
Interventions
nilotinib
2
asciminib
2
Dasatinib
2
Cyclophosphamide
2
fludarabine
1
bosutinib
1
Vincristine
1
Prednisone
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Imatinib Mesylate
1
Etoposide
1
Dexamethasone
1
Daunorubicin
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Philadelphia Chromosome
×
blinatumomab
×
1 year
×
Clear all
No trials found.